Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Antibody”

2,565 trials

Showing 20 of 2,565 results

Early research (Phase 1)Study completedNCT05400265
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

Who this might be right for
Adult Solid Tumor
Shanghai Henlius Biotech 9
Testing effectiveness (Phase 2)WithdrawnNCT03903718
What this trial is testing

Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza

Who this might be right for
Influenza
MedImmune LLC
Testing effectiveness (Phase 2)Study completedNCT03721510
What this trial is testing

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV/AIDS
International AIDS Vaccine Initiative 19
Testing effectiveness (Phase 2)Ended earlyNCT02355184
What this trial is testing

An Extension of Protocol PRO 140_CD01 Study

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 20
Large-scale testing (Phase 3)Study completedNCT03275285
What this trial is testing

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

Who this might be right for
Plasma Cell Myeloma
Sanofi 302
Testing effectiveness (Phase 2)Study completedNCT00869752
What this trial is testing

MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 12
Early research (Phase 1)Study completedNCT02827968
What this trial is testing

Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
3D Medicines (Sichuan) Co., Ltd. 28
Early research (Phase 1)Study completedNCT00369252
What this trial is testing

Phase I Study of Nimotuzumab in Solid Tumours

Who this might be right for
Advanced and/or Metastatic Solid Tumours
YM BioSciences 18
Large-scale testing (Phase 3)Active Not RecruitingNCT06384547
What this trial is testing

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 231
Large-scale testing (Phase 3)WithdrawnNCT02795416
What this trial is testing

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT07208006
What this trial is testing

Very Early PCSK9 Inhibition for Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction (AMI)
Shanghai Zhongshan Hospital 1,518
Testing effectiveness (Phase 2)Study completedNCT06413108
What this trial is testing

Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali

Who this might be right for
Malaria,Falciparum
Radboud University Medical Center 167
Large-scale testing (Phase 3)Study completedNCT04452318
What this trial is testing

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay

Who this might be right for
Healthy Participants
Regeneron Pharmaceuticals 3,303
Testing effectiveness (Phase 2)UnknownNCT03972722
What this trial is testing

Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Guangzhou Gloria Biosciences Co., Ltd. 89
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Early research (Phase 1)Study completedNCT03547037
What this trial is testing

Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers

Who this might be right for
Neoplasm
Janssen Pharmaceutical K.K. 22
Testing effectiveness (Phase 2)Study completedNCT00554606
What this trial is testing

Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Novartis 115
Post-approval studies (Phase 4)Study completedNCT00936143
What this trial is testing

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Who this might be right for
Spondylitis
Gu Jieruo 70
Testing effectiveness (Phase 2)Looking for participantsNCT06981325
What this trial is testing

Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients

Who this might be right for
Basal Cell Carcinoma (BCC)First Line Treatment
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 34
Early research (Phase 1)UnknownNCT03468751
What this trial is testing

Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Henlix, Inc 30
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation